Related Experiment Video
Updated: May 27, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations
Ning Lv1, Xiaoming Xie, Qidong Ge
1Department of Breast Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong 510060, PR China.
Background:
The epidermal growth factor receptor (EGFR) is an available target of effective anti-EGFR therapy for human breast cancer. The aim of this study was to assess the presence of EGFR gene amplification and mutations in breast cancer and to analyze the association between the statuses of these two gene alterations.
Materials And Methods:
EGFR gene amplification and mutations were investigated in formalin-fixed, paraffin-embedded tissues from 139 Chinese female patients with breast cancer by means of fluorescence in-situ hybridization (FISH) and fluorescently labeled real-time quantitative polymerase chain reaction (RT-PCR), respectively.
Results:
EGFR gene amplification was observed in 46/139 (33.1%) of cases by FISH. Based on RT-PCR, 2/139 (1.4%) samples had EGFR gene mutations. Overall, only 1 (0.7%) of the cases was identified with both whole gene amplification and mutation, and 92 (66.2%) of cases were negative for both. High gene copy numbers of EGFR had significant correlation with the occurrence of EGFR protein expressions (P = 0.002).
Conclusion:
In this study, EGFR mutations were presented in only two samples, indicating that EGFR mutations should not be employed in future trials with anti-EGFR therapies for breast cancer. However, EGFR whole gene amplification is frequently observed in patients with breast cancer. It will be of significant interest to investigate whether EGFR gene copy number is a suitable screening test for EGFR-targeted therapy for breast cancer.
Insights
Epidermal growth factor receptor (EGFR) gene amplification is frequent in breast cancer, unlike rare mutations. Gene copy number may be a viable biomarker for anti-EGFR therapy selection in breast cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epidermal growth factor receptor (EGFR) is a therapeutic target in breast cancer.
- Assessing EGFR gene alterations is crucial for targeted therapy selection.
Purpose of the Study:
- To evaluate the prevalence of EGFR gene amplification and mutations in Chinese female breast cancer patients.
- To determine the association between EGFR gene amplification and mutation status.
Main Methods:
- Investigated EGFR gene amplification using fluorescence in-situ hybridization (FISH).
- Analyzed EGFR gene mutations via fluorescently labeled real-time quantitative polymerase chain reaction (RT-PCR).
- Studied 139 formalin-fixed, paraffin-embedded breast cancer tissues.
Main Results:
- EGFR gene amplification detected in 33.1% of cases.
- EGFR gene mutations found in only 1.4% of samples.
- High EGFR gene copy number correlated significantly with EGFR protein expression (P=0.002).
Conclusions:
- EGFR mutations are rare in this cohort, suggesting limited utility in anti-EGFR therapy trials.
- EGFR gene amplification is common and may serve as a predictive biomarker for EGFR-targeted therapies.
- Further research is warranted to validate EGFR gene copy number as a screening tool for breast cancer treatment.
Related Concept Videos
Mitogens and the Cell Cycle
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...